Why did CSURGSU.BO stock fall pre-market on 17 Mar 2026?

CSURGSU.BO stock fell about **18.00%** primarily on heavy selling and above-average volume (574 vs avg 194). No single public corporate release explains the move; traders pointed to profit-taking and liquidity-driven pressure in a thinly traded stock.

What are the key valuation metrics for CSURGSU.BO stock?

Centenial shows EPS **-2.95**, PE **-29.74**, PB **1.04**, price-to-sales **0.59**, and market cap **INR 320,065,359.00**. These signal low market pricing versus book but negative earnings and weak cash flow trends.

What is Meyka AI's short-term forecast for CSURGSU.BO stock?

Meyka AI's forecast model projects a monthly target of **INR 96.49**, a quarterly target of **INR 78.58**, and a 1-year target of **INR 132.51**. These are model outputs and not guarantees; trade sizing should match risk tolerance.

What support and resistance should traders watch for CSURGSU.BO stock?

Watch immediate support at the year low **INR 82.15** and Bollinger lower at **INR 78.47**. Near-term resistance is the 50-day average **INR 95.26** and the 200-day average **INR 117.18**.

IN Stocks

CSURGSU.BO stock down 18% pre-market 17 Mar 2026: support near INR 82.15

ByDanny Kontos March 17, 2026March 17, 2026

CSURGSU.BO stock opened weaker in pre-market trading on 17 Mar 2026 after a sharp decline of -18.00% to INR 87.73. The move followed heavy early selling from an intraday high of INR 106.70, with volume at 574 versus an average of 194, signaling outsized participation. Investors should note Centenial Surgical Suture Limited (CSURGSU.BO) trades on the BSE in India and shows a stretched technical setup between the 50-day average of INR 95.26 and the 200-day average of INR 117.18. We analyse why the stock sits among pre-market top losers and what analysts and models imply next.